24 March 2017 - - The global blood glucose monitoring devices market to grow at a CAGR of 11.81% during the period 2017-2021, according to a new report from Dublin-based Research and Markets.

According to the report, one driver in market is growing prevalence of diabetes in the world.

In 2015, approximately 415 m people in the world had diabetes, which is expected to increase to around 642 m by 2040.

As of 2015, it has been estimated that 9.1% adults in the world have diabetes and this is expected to increase to 10% by 2040.

In addition, 75%-80% of the individuals with diabetes belonged to low- and middle-income countries. The number of people with diabetes is high in APAC.

According to OECD, the prevalent cases are going to reach about 47,973,000 in Europe, 66,812,000 in the Americas, and 18,234,000 in Africa by 2030. The global prevalence of diabetes was estimated to be 9% among adults aged above 18 years.

Key players in this market include Abbott Laboratories, Roche Diagnostics, LifeScan and Medtronic.